Background: Inflammation is linked to cognitive decline in midlife, but the neural basis for this link is unclear. One possibility is that inflammation associates with adverse changes in brain morphology, which accelerates cognitive aging and later dementia risk. Clear evidence is lacking, however, regarding whether inflammation relates to cognition in midlife via changes in brain morphology. Accordingly, the current study examines whether associations of inflammation with cognitive function are mediated by variation in cortical gray matter volume among midlife adults. Methods: Plasma levels of interleukin (IL)-6 and Creactive protein (CRP), relatively stable markers of peripheral systemic inflammation, were assessed in 408 community volunteers aged 30-54 years. All participants underwent structural neuroimaging to assess global and regional brain morphology and completed neuropsychological tests sensitive to early changes in cognitive function. Measurements of brain morphology (regional tissue volumes and cortical thickness and surface area) were derived using Freesurfer. Results: Higher peripheral inflammation was associated with poorer spatial reasoning, short term memory, verbal proficiency, learning and memory, and executive function, as well as lower cortical gray and white matter volumes, hippocampal volume and cortical surface area. Mediation models with age, sex and intracranial volume as covariates showed cortical gray matter volume to partially mediate the association of inflammation with cognitive performance. Exploratory analyses of body mass suggested that adiposity may be a source of the inflammation linking brain morphology to cognition. Conclusions: Inflammation and adiposity might relate to cognitive decline via influences on brain morphology.
Introduction
Aging engenders declines in multiple cognitive domains, including episodic and working memory, attention, and executive functioning (Salthouse, 2004) . Typically, these cognitive declines begin in the late 20s and progress across adulthood (Salthouse, 2004) . Trajectories of cognitive aging are heterogeneous, however, with some individuals showing minimal declines and others more precipitous deterioration (Raz et al., 2005) . Understanding factors that account for individual differences in cognitive aging is critical because age-related impairments in cognitive function confer risk for dementia (Barberger-Gateau et al., 1999; De Lepeleire et al., 2004) , injuries (Sattin, 1992) , hospitalization, and death (Bennett, 1997) .
Preclinical changes in brain morphology precede and may contribute to cognitive declines among healthy aging individuals, as well as predict risk for dementia (Burgmans et al., 2009; den Heijer et al., 2006; Driscoll et al., 2009; Kramer et al., 2007; Persson et al., 2012; Raz et al., 2005; Walhovd et al., 2011) . These changes include reductions in total brain and gray matter volume and in white matter integrity that accompany advancing age (Burgmans et al., 2009; DeCarli et al., 2005; Fjell et al., 2013; Kennedy and Raz, 2009; Raji et al., 2012; Raz et al., 2005; Ryan et al., 2011) . On average, reductions in gray matter volume begin around age 35 and accelerate thereafter (Fjell et al., 2013; Hedman et al., 2012) , associating with concomitant and future declines in cognitive function (Burgmans et al., 2009; Fjell and Walhovd, 2010; Kramer et al., 2007) . Individuals differ in rates of age-related brain atrophy, with accelerated gray matter loss associated with earlier progression to dementia (Whitwell et al., 2008 
